XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.2
Note 7 - Stockholders' Equity
 6 Months Ended
Jun. 30, 2025
Notes to Financial Statements  
Equity [Text Block]

NOTE 7— STOCKHOLDERS’ EQUITY

 

PUBLIC OFFERING 

 

On  January 12, 2024 the underwriter exercised its over-allotment option as to 372,110 shares of common stock for net proceeds after discounts and commission of $192,156.

 

SHARES TO BE ISSUED

 

As of June 30, 2025 and 2024, there were 3,076,871 and 2,657,058, respectively, shares to be issued whose issuance has been deferred under the terms of employment and consulting agreements with officers and directors and other employees of Milestone Scientific. Such shares will be issued to each party upon termination of their employment or other relationship with the Company. 

 

As of June 30, 2025 and 2024, there were 631,792 and 527,625, respectively, shares to be issued to non-employees, that will be issued to non-employees for services rendered. The number of shares was fixed by contract prior to the date of grant, subject to performance, and were fully earned upon the grant date.

 

The following table summarizes information about shares to be issued for the six month periods ending June 30, 2025 and 2024.

 

 

  

June 30, 2025

  

June 30, 2024

 
         

Shares-to-be-issued, outstanding January 1, 2025 and 2024, respectively

  3,393,017   3,098,917 

Granted in current period

  315,646   438,868 

Issued in current period

  -   (353,102)

Shares-to be issued outstanding June 30, 2025 and 2024, respectively

  3,708,663   3,184,683